Problem

Opalite Health addresses the safety, speed, and cost problems created when clinicians and patients cannot communicate in the same language. The company’s origin story describes a 15-minute wait for a phone interpreter, incomplete interpretation, a misdiagnosis, and the wrong medication. In routine care, providers may spend time dialing and waiting for interpreters, worry that a missed word such as “no” could reverse clinical meaning, and document the encounter manually while trying to communicate. The main use case is therefore live medical interpretation during visits, especially in high-volume settings such as community health centers serving large non-English-speaking populations.

The economics are meaningful because traditional phone and video interpretation is billed by the minute and adds time to every visit. Opalite’s CIFC Health case study reports that the clinic serves roughly 40,000 patients annually and saved more than $5,000 per month after replacing conventional services, while interpreted visits became 8.3 minutes shorter on average. This makes language access not only a patient-safety and equity issue, but also a material operating-cost and throughput problem for healthcare organizations.

Product / Service

Opalite is a voice-based AI medical interpreter designed to operate inside existing clinical workflows. It provides bidirectional, real-time interpretation in more than 150 languages and dialects, is available instantly around the clock, and can be used on the phones, tablets, and computers clinicians already have. The platform integrates with the EHR and produces clinical notes and an audit record, while its Guardian layer checks sentences for safety. The company positions the product as deployment-ready for regulated care, citing HIPAA compliance, SOC 2 Type II controls, and Section 1557 language-access workflows.

The benefit is faster communication without waiting for a human interpreter, less clinician documentation burden, lower interpretation cost, and more consistent quality. Opalite says its accuracy was tested in a blinded clinical evaluation against certified interpreters with physician-researchers from Johns Hopkins Medicine and the U.S. Department of Veterans Affairs; the study reports more than 90% fewer errors overall, with the largest reductions in Cantonese, Mandarin, and Spanish. At CIFC, more than 50 staff use the product daily, and the organization reports a 50% reduction in interpretation costs and a 22.5% reduction in interpreted-visit duration.

Market

Opalite competes in healthcare language access and medical interpretation, specifically the emerging category of AI-native, workflow-embedded interpretation software. Its traditional competitors include LanguageLine Solutions and AMN Healthcare’s interpreter services, while AI-oriented alternatives include Boostlingo and other voice-AI interpretation products. Opalite’s differentiation is the combination of speech-to-speech interpretation, medical terminology and safety checks, EHR-connected documentation, auditability, and a claimed cost advantage over per-minute human interpretation.

The company is not merely pre-product: Y Combinator lists Opalite as an active Winter 2026 company, and its profile says patients and providers use it daily across more than 10 states. The company identifies hospitals, community health centers, home-health organizations, telehealth providers, and clinics as customers, and its website names multiple healthcare organizations, including CIFC Health and Blythedale Children’s Hospital. Public evidence therefore indicates early commercial traction, including a documented CIFC deployment, although publicly available materials do not provide a dependable revenue figure or comprehensive usage metrics.